Results 1 to 10 of about 95,560 (244)
Esophagitis in a high H. pylori prevalence area: severe disease is rare but concomitant peptic ulcer is frequent. [PDF]
PLoS ONE, 2011 BACKGROUND: Few data are available on the prevalence of erosive and severe esophagitis in Western countries. OBJECTIVE: To retrospectively determine the prevalence and the factors predicting erosive esophagitis and severe esophagitis in a large series of
Julio Ponce +5 more
doaj +2 more sources
Long peptic strictures of the esophagus due to reflux esophagitis: a case report [PDF]
Surgery Case Reports, 2016 BackgroundMost of benign esophageal strictures caused by gastroesophageal reflux are short segments and can be treated by an endoscopic dilatation, but cases of long-segment stenosis requiring an esophagectomy are rare.Case presentationA 62-year-old ...
Y. Yamasaki +4 more
core +2 more sources
Arquivos de Gastroenterologia, 2009 CONTEXT: Whether Helicobacter pylori infection is a protective or predisposing factor for the development of gastroesophageal reflux disease remains controversial. The most virulent strains, such as those expressing the cytotoxin-associated gene A (CagA),
Carlos Alexandre Gonçalves Batista +5 more
doaj +2 more sources
Journal of Research in Medical Sciences, 2022 Background: Chronic dyspepsia's symptoms are frequently seen in primary to tertiary healthcare in Indonesia. This study aimed to describe the potential usability of pepsinogen (PG) values in determining gastric mucosal conditions, including superficial ...
Muhammad Miftahussurur +25 more
doaj +2 more sources
Nissen Fundoplication for Reflux Peptic Esophagitis
Annals of Surgery, 1977 One hundred sixty-five patients with reflux peptic esophagitis have been treated by Nissen fundoplication. When compared with a group of 104 patients reported five years ago, the incidence of persistent or recurrent esophagitis remains approximately the same (10% versus 8%).
Frederic L. Bushkin +3 more
openaire +5 more sources
Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders [PDF]
The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2023 Owing to their superior pharmacokinetic and pharmacodynamic profiles, potassium-competitive acid blockers (P-CABs) score over proton pump inhibitors (PPIs) in the treatment of gastric acid-related disorders and may provide clinical benefit in the ...
Mun Young Cho, Yu Kyung Cho
doaj +1 more source
Gastroprotective effects of methanolic extract of kratom leaves on gastric ulcer and reflux esophagitis in rats [PDF]
Songklanakarin Journal of Science and Technology (SJST), 2018 Kratom (Mitragyna speciosa (Korth.) Havil.) is a tropical tree indigenous to Thailand. In traditional medicine, it has been used to treat diarrhea, peptic ulcer, stomach ache or gastric upsets.
Somsmorn Chittrakarn +5 more
doaj +1 more source
The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2022 Histamine H2 receptor antagonists (H2RAs) suppress gastric acid production by blocking H2 receptors in parietal cells. Studies have shown that proton pump inhibitors (PPIs) are superior to H2RAs as a treatment for acid-related disorders, such as peptic ...
Cheol Min Shin
doaj +1 more source
A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children
Frontiers in Pharmacology, 2022 Proton pump inhibitors (PPIs) are among the most prescribed drugs worldwide and include omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole.
Valeria Dipasquale +3 more
doaj +1 more source
Annals medicus, 2020 Introduction Recent prevalence and trends of gastric/duodenal ulcer (GU/DU) and reflux esophagitis (RE) are inadequate. Methods We reviewed the records of consecutive 211,347 general population subjects from 1991 to 2015. Results During the 25 years, the
N. Yamamichi +7 more
semanticscholar +1 more source